Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Coiffier

Showing results (31-40 of 249) with videos related to

Pageof 25
Sort By:
Oncology (Williston Park, N.Y.)|March 28, 2013
When can R-CHOP not be used in an elderly patient?Bertrand Coiffier
Tumori|May 7, 2002
Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphomaBertrand Coiffier
The Oncologist|October 27, 2005
Response to "effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia"Bertrand Coiffier
Current Hematology Reports|August 7, 2003
Monoclonal antibodies in the management of newly diagnosed, aggressive B-cell lymphomaBertrand Coiffier
Clinical Lymphoma|January 11, 2003
Treatment paradigms in aggressive non-Hodgkin's lymphoma in elderly patientsBertrand Coiffier
Future Oncology (London, England)|May 10, 2017
Preparing for a new generation of biologic therapies: understanding the development and potential of biosimilar cancer therapeuticsBertrand Coiffier
Nature Reviews. Clinical Oncology|February 1, 2012
Hematological cancer: Localized non-bulky Hodgkin lymphoma--future questionsBertrand Coiffier, Olivier Casasnovas
Lancet (London, England)|April 7, 2012
Escalated BEACOPP in advanced Hodgkin's lymphomaOlivier Casasnovas, Bertrand Coiffier
Blood|August 20, 2004
Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphomaBertrand Coiffier, Gilles Salles
Best Practice & Research. Clinical Haematology|February 8, 2005
Radio-immunotherapy in low-grade non-Hodgkin's lymphomaBernard Lemieux, Bertrand Coiffier
Pageof 25

Showing results (31-40 of 249) with videos related to

Sort By:
Pageof 25
Oncology (Williston Park, N.Y.)|March 28, 2013
When can R-CHOP not be used in an elderly patient?Bertrand Coiffier
Tumori|May 7, 2002
Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphomaBertrand Coiffier
The Oncologist|October 27, 2005
Response to "effect of patient exclusion criteria on the efficacy of erythropoiesis-stimulating agents in patients with cancer-related anemia"Bertrand Coiffier
Current Hematology Reports|August 7, 2003
Monoclonal antibodies in the management of newly diagnosed, aggressive B-cell lymphomaBertrand Coiffier
Clinical Lymphoma|January 11, 2003
Treatment paradigms in aggressive non-Hodgkin's lymphoma in elderly patientsBertrand Coiffier
Future Oncology (London, England)|May 10, 2017
Preparing for a new generation of biologic therapies: understanding the development and potential of biosimilar cancer therapeuticsBertrand Coiffier
Nature Reviews. Clinical Oncology|February 1, 2012
Hematological cancer: Localized non-bulky Hodgkin lymphoma--future questionsBertrand Coiffier, Olivier Casasnovas
Lancet (London, England)|April 7, 2012
Escalated BEACOPP in advanced Hodgkin's lymphomaOlivier Casasnovas, Bertrand Coiffier
Blood|August 20, 2004
Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphomaBertrand Coiffier, Gilles Salles
Best Practice & Research. Clinical Haematology|February 8, 2005
Radio-immunotherapy in low-grade non-Hodgkin's lymphomaBernard Lemieux, Bertrand Coiffier
Pageof 25